Aktinos Pharma Private Limited, a amalgamated private limited company, was established on 13 September 2007 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232TG2007PTC055510. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹4.03 Cr.
It upholds a compliant status. Employing 411 professional, Its leadership includes Murali Krishna Madala (Managing Director), Vineeth Madala (Director), Ravishanker Kovi (Director). Past directors included Murali Krishna Madala, Madhavi Thirividhi, Vineeth Madala. It holds ₹104.88 Cr open charges and ₹50.36 Cr settled loans. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at Sri Lakshmi Spaces, 5Th Floor, Plot No. 7, Block No. B, Kavuri Hills, Phase- I, Mad, Hapur, Hyderabad, Telangana, 500033.
U24232TG2007PTC055510
055510
13 September 2007
₹20.00 Cr
₹4.03 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Aktinos Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Murali Krishna Madala | Managing Director | 13 Sep 2007 | Current |
| Vineeth Madala | Director | 01 Aug 2022 | Current |
| Ravishanker Kovi | Director | 24 Jul 2017 | Current |
| Srilakshmi Madala | Whole-Time Director | 13 Sep 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2007 | Past |
| Pramod Abcsdd | Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Aug 2023 | Past |
| Pramod Abcsdd | Whole-Time Director | 28 Nov 2015 | Past |
| Pramod Abcsdd | Director | 01 Oct 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aktinos Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 8873335.3% increase. The company also saw a substantial fall in profitability, with a 203180804.24% decrease in profit. The company's net worth Soared by an impressive increase of 7260873.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aktinos Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,048,765,785.00
₹503,642,196.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2023 | Others | ₹1.71 Cr | Satisfied |
| 28 Feb 2022 | Others | ₹1.38 Cr | Satisfied |
| 22 Apr 2021 | Others | ₹5.00 Cr | Satisfied |
| 03 Apr 2017 | Axis Bank Limited | ₹16.32 Cr | Satisfied |
| 02 Jul 2012 | Others | ₹17.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Aktinos Pharma has a workforce of 411 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aktinos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aktinos Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 28 Feb 2023 via Charge ID 100695749 with Others was fully satisfied on 19 Mar 2025. was completed.
A charge registered on 28 Feb 2022 via Charge ID 100559027 with Others was fully satisfied on 19 Mar 2025. was recorded as a recent event.
Progress on A charge registered on 22 Apr 2021 via Charge ID 100443999 with Others was fully satisfied on 30 Jan 2025. was documented.
Aktinos Pharma Private Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was recorded as a recent event.
The activity Aktinos Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge registered on 03 Apr 2017 via Charge ID 100094654 with Axis Bank Limited was fully satisfied on 01 Mar 2023. was recorded as a recent event.
The CIN of Aktinos Pharma Private Limited is U24232TG2007PTC055510.
Aktinos Pharma Private Limited is headquartered at Sri Lakshmi Spaces, 5Th Floor, Plot No. 7, Block No. B, Kavuri Hills, Phase- I, Mad, Hapur, Hyderabad, Telangana, 500033.
Aktinos Pharma Private Limited was incorporated on 13 September 2007.
The current directors of Aktinos Pharma Private Limited are
The primary industry of Aktinos Pharma Private Limited is Manufacturing.
Aktinos Pharma Private Limited is unlisted.
The authorized capital of Aktinos Pharma Private Limited is ₹20.00 Cr, and the paid-up capital is ₹4.03 Cr.
The compliance status of Aktinos Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX